Background: This study compared clinical and hemodynamic in-hospital outcomes of patients undergoing sutureless vs rapid deployment aortic valve replacement (SURD-AVR) in the large population of the Sutureless and Rapid Deployment International Registry (SURD-IR). Methods: We examined 4695 patients who underwent isolated or combined SURD-AVR. The “sutureless” Perceval valve (LivaNova PLC, London, United Kingdom) was used in 3133 patients and the “rapid deployment” Intuity (Edwards Lifesciences, Irvine, CA) in 1562. Potential confounding factors were addressed by the use of propensity score matching. After matching, 2 well-balanced cohorts of 823 pairs (isolated SURD-AVR) and 467 pairs (combined SURD-AVR) were created. Results: Patients who ...
The treatment options for patients with aortic valve disease have considerably expanded over the las...
Objective: To define the benefit of sutureless and rapid deployment valves in current minimally inva...
Background: New technologies such as sutureless or rapid deployment prosthetic valves and access via...
OBJECTIVES: The impact of sutureless and rapid deployment (SURD) valves on the clinical outcomes of ...
OBJECTIVES:Current evidence on sutureless and rapid deployment aortic valve replacement (SURD-AVR) i...
OBJECTIVES: Current evidence on sutureless and rapid deployment aortic valve replacement (SURD-AVR) ...
Abstract OBJECTIVES: The Sutureless and Rapid-Deployment Aortic Valve Replacement International ...
Objectives: The aim of this retrospective multicenter study was to compare early clinical and hemody...
BACKGROUND Reoperation for aortic valve replacement can be challenging and is usually associated ...
Sutureless or rapid deployment valves in the setting of aortic valve replacement (AVR) is an emergin...
OBJECTIVES: The ideal strategy for the treatment of severe aortic valve stenosis in patients of vary...
Background: Sutureless and rapid-deployment aortic valve replacement (SURD-AVR) has become a promine...
BACKGROUND: Reoperation for aortic valve replacement can be challenging and is usually associated wi...
Background: Benefits of sutureless and rapid deployment (SURD) bioprostheses in bicuspid aortic valv...
The treatment options for patients with aortic valve disease have considerably expanded over the las...
Objective: To define the benefit of sutureless and rapid deployment valves in current minimally inva...
Background: New technologies such as sutureless or rapid deployment prosthetic valves and access via...
OBJECTIVES: The impact of sutureless and rapid deployment (SURD) valves on the clinical outcomes of ...
OBJECTIVES:Current evidence on sutureless and rapid deployment aortic valve replacement (SURD-AVR) i...
OBJECTIVES: Current evidence on sutureless and rapid deployment aortic valve replacement (SURD-AVR) ...
Abstract OBJECTIVES: The Sutureless and Rapid-Deployment Aortic Valve Replacement International ...
Objectives: The aim of this retrospective multicenter study was to compare early clinical and hemody...
BACKGROUND Reoperation for aortic valve replacement can be challenging and is usually associated ...
Sutureless or rapid deployment valves in the setting of aortic valve replacement (AVR) is an emergin...
OBJECTIVES: The ideal strategy for the treatment of severe aortic valve stenosis in patients of vary...
Background: Sutureless and rapid-deployment aortic valve replacement (SURD-AVR) has become a promine...
BACKGROUND: Reoperation for aortic valve replacement can be challenging and is usually associated wi...
Background: Benefits of sutureless and rapid deployment (SURD) bioprostheses in bicuspid aortic valv...
The treatment options for patients with aortic valve disease have considerably expanded over the las...
Objective: To define the benefit of sutureless and rapid deployment valves in current minimally inva...
Background: New technologies such as sutureless or rapid deployment prosthetic valves and access via...